Homologous Recombination Deficiency Clinical Trials
0 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 1
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Breast CancerOvarian CancerProstate Cancer+4 more
MOMA Therapeutics220 enrolled18 locationsNCT06545942
Recruiting
Phase 2
Olaparib in Patients With HRD Malignant Mesothelioma
Homologous Recombination DeficiencyMesothelioma
University of Chicago56 enrolled1 locationNCT04515836
Recruiting
Phase 1Phase 2
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Breast CancerPancreatic CancerOvarian Cancer+3 more
AtlasMedx, Incorporated122 enrolled4 locationsNCT04503265